The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years.
Saved in:
| Title: | The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. |
|---|---|
| Authors: | He XM; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., He MC; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Yang P; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Zhang QW; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Chen ZQ; The Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., He W; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Wei QS; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Nov 23; Vol. 12, pp. 773758. Date of Electronic Publication: 2021 Nov 23 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34899331 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22He+XM%22">He XM</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22He+MC%22">He MC</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yang+P%22">Yang P</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+QW%22">Zhang QW</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+ZQ%22">Chen ZQ</searchLink>; The Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22He+W%22">He W</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wei+QS%22">Wei QS</searchLink>; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Nov 23; Vol. 12, pp. 773758. <i>Date of Electronic Publication: </i>2021 Nov 23 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34899331 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2021.773758 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 773758 Titles: – TitleFull: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: He XM – PersonEntity: Name: NameFull: He MC – PersonEntity: Name: NameFull: Yang P – PersonEntity: Name: NameFull: Zhang QW – PersonEntity: Name: NameFull: Chen ZQ – PersonEntity: Name: NameFull: He W – PersonEntity: Name: NameFull: Wei QS IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 11 Text: 2021 Nov 23 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 12 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
